[{"address1": "930 Winter Street", "address2": "Suite M-500", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "617 443 2400", "website": "https://aerovatetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 51, "companyOfficers": [{"maxAge": 1, "name": "Mr. Timothy P. Noyes M.B.A.", "age": 61, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 936899, "exercisedValue": 0, "unexercisedValue": 10446414}, {"maxAge": 1, "name": "Mr. George A. Eldridge", "age": 60, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 658600, "exercisedValue": 0, "unexercisedValue": 1968391}, {"maxAge": 1, "name": "Dr. Benjamin T. Dake Ph.D.", "age": 47, "title": "Founder, President, COO & Secretary", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 435500, "exercisedValue": 0, "unexercisedValue": 975487}, {"maxAge": 1, "name": "Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 372333, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hunter  Gillies M.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 512742, "exercisedValue": 0, "unexercisedValue": 313002}, {"maxAge": 1, "name": "Ms. Donna  Dea", "title": "Head of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  Fischer", "title": "Executive Vice President of Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen K. Yu", "title": "Senior Vice President of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sanjeev  Khindri", "title": "Executive Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheryl  Lassen BSc., M.D., MBBCh", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1733011200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.63, "open": 2.63, "dayLow": 2.57, "dayHigh": 2.69, "regularMarketPreviousClose": 2.63, "regularMarketOpen": 2.63, "regularMarketDayLow": 2.57, "regularMarketDayHigh": 2.69, "forwardPE": -5.7419357, "volume": 110350, "regularMarketVolume": 110350, "averageVolume": 776038, "averageVolume10days": 216260, "averageDailyVolume10Day": 216260, "bid": 2.61, "ask": 2.72, "bidSize": 100, "askSize": 100, "marketCap": 77189968, "fiftyTwoWeekLow": 1.25, "fiftyTwoWeekHigh": 32.415, "fiftyDayAverage": 2.5428, "twoHundredDayAverage": 8.7775, "currency": "USD", "enterpriseValue": -15154691, "floatShares": 11847020, "sharesOutstanding": 28910100, "sharesShort": 1791792, "sharesShortPriorMonth": 549747, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.062, "heldPercentInsiders": 0.00029, "heldPercentInstitutions": 1.02169, "shortRatio": 0.98, "shortPercentOfFloat": 0.1575, "impliedSharesOutstanding": 28910100, "bookValue": 2.788, "priceToBook": 0.95767576, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -84611000, "trailingEps": -2.99, "forwardEps": -1.0, "enterpriseToEbitda": 0.168, "52WeekChange": -0.8775791, "SandP52WeekChange": 0.25891924, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "AVTE", "underlyingSymbol": "AVTE", "shortName": "Aerovate Therapeutics, Inc.", "longName": "Aerovate Therapeutics, Inc.", "firstTradeDateEpochUtc": 1625059800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "cbf275de-3fc7-3baa-b402-2df34de7643f", "messageBoardId": "finmb_650355034", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.67, "targetHighPrice": 3.0, "targetLowPrice": 2.0, "targetMeanPrice": 2.33333, "targetMedianPrice": 2.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 88730000, "totalCashPerShare": 3.074, "ebitda": -89957000, "totalDebt": 540000, "quickRatio": 8.602, "currentRatio": 8.784, "debtToEquity": 0.671, "returnOnAssets": -0.48666, "returnOnEquity": -0.82061, "freeCashflow": -48156876, "operatingCashflow": -74949000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-28"}]